- Home
- PSTV vs SVRE Comparison
PSTV vs SVRE Comparison
Compare PSTV & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSTV | SVRE |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 1.5M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | PSTV | SVRE |
|---|---|---|
| Price | $0.29 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 10.2M | 2.1M |
| Earning Date | 10-30-2025 | 12-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,258,000.00 | $580,536.00 |
| Revenue This Year | $1.73 | $453.30 |
| Revenue Next Year | $12.05 | $106.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.19 |
| 52 Week Low | $0.16 | $1.21 |
| 52 Week High | $2.31 | $111.60 |
Technical Indicators
Market Signals| Indicator | PSTV | SVRE |
|---|---|---|
| Relative Strength Index (RSI) | 26.25 | 57.09 |
| Support Level | $0.25 | $1.32 |
| Resistance Level | $0.61 | $1.54 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 10.67 | 69.33 |
Price Performance
Historical ComparisonAbout PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.